EYE vs RHT

ASX Healthcare sector comparison — updated 26 Mar 2026 — Healthcare sector

EYE

NOVA EYE FPO [EYE]

55MEDIUM

RHT

RESONANCE FPO [RHT]

55MEDIUM

Score Breakdown

EYE RHT
Technical
38
39
Catalyst
50
53
Sentiment
50
50
Fundamental
63
82
Momentum
60
64
Risk Gate
45
42

Key Metrics

EYE Metric RHT
$37.0MMarket Cap$19.1M
335KAvg Volume (20d)300K
N/AShort InterestN/A
$0.20552-Week High$0.059
$0.08652-Week Low$0.033
-3.8%Daily Change+2.5%
$0.125Entry Price$0.041
-42.4%ROE+7.3%
-21.3%Profit Margin+5.6%

Active Signals

EYE Signals

●RSI drifting toward oversold territory — worth watching
●Trading below both moving averages — the trend is working against this one
●Drifting lower — down 3.8% over the last 5 days
●Below the 200-day average — the long-term trend is still working against it
●Low cash runway (2 quarters) - dilution risk
●Low P/S ratio (1.1x)
●Strong revenue growth (+29%)
●EPS estimates revised upward (+10pts)

RHT Signals

●MACD momentum is picking up steam
●Stochastic is stretched into overbought — could need a breather
●Volume surging at 2.2x normal while price falls — heavy selling pressure
●Watch out — volume is flowing out even as price holds up. Distribution pattern
●Volatility is contracting — like a spring being compressed, breakouts often follow
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Low P/S ratio (1.4x)

Ask Scout AI to compare EYE and RHT in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
EYE Full Analysis → RHT Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).